Withdrawal of Registration Statement (rw)
October 24 2014 - 5:05PM
Edgar (US Regulatory)
Angion
Biomedica Corp.
51 Charles Lindbergh Boulevard
Uniondale, NY 11553
Phone: 516-326-1200
Fax: 516-307-1659
www.angion.com
October 24, 2014
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Re: |
Angion Biomedica Corp. |
|
Registration Statement on S-1 |
|
Filed April 14, 2014 |
|
Amendment No. 1 filed May 23, 2014 |
|
and Amendment No. 2 filed August 25, 2014 |
|
File No. 333-195261 |
Dear Sir or Madam:
Pursuant to Rule 477 promulgated under the
Securities Act of 1933, as amended (the “Act”), Angion Biomedica Corp. (“Angion”) respectfully requests
the immediate withdrawal of its Registration Statement on Form S-1 (File No. 333-195261) together with all amendments and exhibits
thereto (collectively, the “Registration Statement”), originally filed with the Securities and Exchange Commission
(the “Commission”) on April 14, 2014, as amended by Amendment No. 1 filed on May 23, 2014, and Amendment No. 2 filed
on August 25, 2014.
Angion requests the withdrawal of the Registration
Statement due to current market conditions being unfavorable to proceeding with the offering at this time. The Registration Statement
has not been declared effective by the Commission, and Angion confirms that no securities have been or will be sold pursuant to
the Registration Statement or the prospectus contained therein. Angion believes that the withdrawal of the Registration Statement
is consistent with the public interest and protection of investors, as contemplated by Rule 477.
Angion may undertake a subsequent private
offering in reliance on Rule 155(c) under the Act.
October 24, 2014
Page 2
It is our understanding that this
request for withdrawal of the Registration Statement will be deemed granted as of the date that it is filed with the
Commission unless, within fifteen days after such date, Angion receives a notice from the Commission that this request will
not be granted.
Angion acknowledges that no refund will be
made for fees paid to the Commission in connection with the filing of the Registration Statement. However, Angion requests, in
accordance with Rule 457(p) under the Act, that all fees paid to the Commission in connection with the filing of the Registration
Statement be credited to Angion’s account to be offset against the filing fee for the filing of any future registration
statement or registration statements.
We appreciate your assistance, and should
you have any questions, please feel free to contact me at (516) 326-1200.
Sincerely,
/s/ Michael A. Yamin
Michael A. Yamin, Ph.D.
Vice President
Angion Biomedica (NASDAQ:ANGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Angion Biomedica (NASDAQ:ANGN)
Historical Stock Chart
From Apr 2023 to Apr 2024